| Literature DB >> 33403789 |
Qiaosi Tang1,2, Ashley Lento1, Kensuke Suzuki2, Gizem Efe2, Tatiana Karakasheva3, Apple Long1, Véronique Giroux4, Mirazul Islam5, E Paul Wileyto1,6, Andres J Klein-Szanto7, Hiroshi Nakagawa2, Adam Bass8, Anil K Rustgi2.
Abstract
Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer worldwide. The most commonly mutated gene in ESCC is TP53. Using a combinatorial genetic and carcinogenic approach, we generate a novel mouse model of ESCC expressing either mutant or null p53 and show that mutant p53 exhibits enhanced tumorigenic properties and displays a distinct genomic profile. Through RNA-seq analysis, we identify several endocytic recycling genes, including Rab Coupling Protein (Rab11-FIP1), which are significantly downregulated in mutant p53 tumor cells. In 3-dimensional (3D) organoid models, genetic knockdown of Rab11-FIP1 results in increased organoid size. Loss of Rab11-FIP1 increases tumor cell invasion in part through mutant p53 but also in an independent manner. Furthermore, loss of Rab11-FIP1 in human ESCC cell lines decreases E-cadherin expression and increases mesenchymal lineage-specific markers, suggesting induction of epithelial-mesenchymal transition (EMT). Rab11-FIP1 regulates EMT through direct inhibition of Zeb1, a key EMT transcriptional factor. Our novel findings reveal that Rab11-FIP1 regulates organoid formation, tumor cell invasion, and EMT.Entities:
Keywords: Epithelial-Mesenchymal transition; Rab coupling protein (Rab11-FIP1); esophageal cancer; invasion
Mesh:
Year: 2021 PMID: 33403789 PMCID: PMC7857540 DOI: 10.15252/embr.201948351
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807